Author

R.-U. Rahman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Assay:metagenomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

H. Amatullah· 2 shared A. C. Mullen· 1 shared C. Sun· 1 shared D. Wrobel· 1 shared F. Adiliaghdam· 1 shared I. Fraschilla· 1 shared J. F. Doerner· 1 shared J. F. Rippmann· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. Amatullah

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease

I. Fraschilla, H. Amatullah, R.-U. Rahman, K. Jeffrey

This study identifies SP140's role in regulating microbiota and preventing inflammatory bowel disease by controlling inflammatory bacteria.

bioRxiv · Mar 29, 2022Immunology

Human enteric viruses shape disease phenotype through divergent innate immunomodulation

F. Adiliaghdam, H. Amatullah, S. Digumarthi, T. L. Saunders, R.-U. Rahman, L. P. Wong, R. Sadreyev, L. Droit, J. Paquette, P. Goyette, J. Rioux, R. Hodin, K. Mihindukulasuriya, S. A. Handley, K. L. Jeffrey

The paper shows that human viromes from healthy and IBD patients differentially modulate innate immunity, influencing disease phenotypes through nucleic acid sensing.

bioRxiv · Oct 14, 2021 · PreprintImmunology

Nanchangmycin regulates FYN, FAK and ERK to control the fibrotic activity of hepatic stellate cells

W. Li, J. Y. Chen, C. Sun, R. P. Sparks, L. Pantano, R.-U. Rahman, S. P. Moran, J. V. Pondick, R. Kirchner, D. Wrobel, M. Bieler, S. J. Ho Sui, J. F. Doerner, J. F. Rippmann, A. C. Mullen

This study identifies nanchangmycin as an anti-fibrotic agent that inhibits HSC myofibroblast activity by modulating FYN, FAK, and ERK signaling pathways.

bioRxiv · Oct 8, 2021Cell Biology